Video Experimental Relacionado
Updated: Jan 7, 2026

09:32
A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies
Published on: September 23, 2014
24.6K
Marcadores tumorales y patología basada en la evidencia
Kateryna Maslova1, Magdalena Chechlinska1, Irmina Maria Michalek2
1Laboratory of Cancer Biology, Department of Experimental Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Resumen
No abstract available in PubMed .
Palabras clave:
Validación de los biomarcadoresDiagnóstico del cáncerPruebas de las Mapas de la Brecha (EGM)Patología basada en la evidenciajerarquía de la evidencia para la patología tumoral (HETP)Cuidados personalizados contra el cáncerBiomarcadores de los tumoresClasificación del tumorMás Videos Relacionados
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
17.0K
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.8K
Videos de Conceptos Relacionados
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer Survival Analysis
626
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
626